Emtora Biosciences is a life science company developing a novel formulation of rapamycin, eRapa™, for use in preventing the onset and recurrence of cancer. A Phase 1b safety and dosing clinical trial is underway in early stage prostate cancer patients. A pilot efficacy study in Familial Adenomatous Polyposis (FAP) is planned for late 2019.
Company Details
- Employees
- 2
- Address
- San Antonio, Tx 78232, Us
- Phone
- (210) 381-2486
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- emtorabio.com
- Keywords
- San Antonio.
- HQ
- San Antonio, TX
Emtora Biosciences Questions
Emtora Biosciences's helpline number is (210) 381-2486
Emtora Biosciences's website is emtorabio.com
Emtora Biosciences's LinkedIn profile is https://www.linkedin.com/company/emtora-biosciences
Emtora Biosciences has
2 employees.
View email and phone details for 2
employees at Emtora Biosciences.
Emtora Biosciences's industry is
Biotechnology Research
Emtora Biosciences's top competitors are
Lumabridge,
Tvardi Therapeutics,
Elios Therapeutics, Llc,
Plus Therapeutics, Inc.,
Triumvira Immunologics, Inc.,
4e Therapeutics Inc.,
Vuja De Sciences,
Coya Therapeutics, Inc.,
Biodexa Pharmaceuticals Plc,
Aegle Therapeutics.
Emtora Biosciences's categories are Biotechnology Research
